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Background: The surface markers of mesenchymal stem cells (MSCs) of rabbits have been reported only
sporadically. However, interest in the spinal fusion effect of MSCs has risen recently. The purpose of this research
was to study the surface markers and spinal fusion effect of rabbit MSCs.
Results: Of our rabbit MSCs, 2% expressed CD14, CD29, and CD45, 1% expressed CD90 and 97% expressed CD44.
These results implied the MSCs were negative for CD14, CD29, CD45, and CD90, but positive for CD44. The surgical
results showed that satisfactory fusion occurred in 10 rabbits (83%) in the study group and unsatisfactory fusion in
2 (17%). In the control group, satisfactory fusion was found in 3 rabbits (25%) and unsatisfactory fusion in 9 (75%).
Statistical analysis showed the study group had significantly better spinal fusion results than the control group.
Conclusions: The surface markers of human and rabbit MSCs are not exactly the same. Rabbit MSCs do not have
positive reactivity for CD29 and CD90, which are invariably present on human MSCs. The allogeneic undifferentiated
rabbit MSCs were able to promote spinal fusion and did not induce an adverse immune response.
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Biological and clinical interest in mesenchymal stem
cells (MSCs) has risen dramatically over the past two de-
cades [1,2]. MSCs are multipotent cells that can replicate
and have the potential to differentiate to lineages of
mesenchymal tissues, including bone, cartilage and fat
[2]. MSCs can be isolated from bone marrow and ex-
panded in cultures. Adult bone marrow contains a het-
erogeneous population of cells, including hematopoietic
stem cells, macrophages, erythrocytes, fibroblasts, adipo-
cytes, and endothelial cells. In addition to these cell
types, bone marrow also contains a subset of nonhema-
topoietic stem cells that possess a multilineage potential
[3,4]. These properties make bone marrow-derived MSCs
a good candidate for potential therapeutic applications
such as cellular and gene therapies, tissue engineering and
other preclinical investigations [5]. Human MSCs are
characterized by the presence of a consistent set of marker* Correspondence: isaac87723@gmail.com
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reproduction in any medium, provided the orproteins on their surface, including CD29, CD44, CD71,
CD90, CD105, and an absence of marker proteins of
hematopoietic lineage and leukocytes, including CD14,
CD34, CD45 [2]. However, sporadic reports have suggested
that the MSC surface markers of humans and rabbits may
not be exactly the same [6,7].
The aim of the current study was to investigate the sur-
face markers of rabbit MSCs using rabbit-specific anti-
bodies and flow cytometry, and to determine whether
allogeneic undifferentiated MSCs have the same good
fusion effect as autologous differentiated MSCs, which
have been advocated recently by other investigators [8].
Methods
Isolation and culture of rabbit bone marrow MSCs
The femurs of rabbits were harvested under general
anesthesia and sterile conditions. Muscle and all con-
nective tissue were detached from the femurs. The ends
of the bones were cut away and an 18-gauge needle was
inserted into the femoral shafts. The bone marrow of
the shafts was extruded by flushing with low-glucose
Dulbecco's Modified Eagle Medium (DMEM-LG; Gibco-
BRL, Carlsbad, CA) supplemented with 10% fetal bovine. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cillin (Hyclone, Logan, UT) and 100 μg/ml streptomycin
(Hyclone, Logan, UT). Marrow plug suspension was
dispersed by pipetting, filtered through a 70-μm mesh
nylon filter (Becton Dickinson Biosciences, Bedford, MA),
and centrifuged at 400 × g for 5 minutes. The pellet was
resuspended in the RBC lysis buffer (0.154 M NH4Cl,
10 mM KHCO3 and 0.1 mM EDTA) (Panreac, Barcelona,
Spain) for 5 minutes to lyse the red blood cells and centri-
fuged at 400 × g for 5 minutes. The supernatant was dec-
anted by pipetting. Cells of 1 × 107 were seeded in tissue
culture plate (100 mm diameter) and incubated at 37°C in
5% CO2. After 4 days of incubation, the non-adherent cells
were removed by replacing the medium. Thereafter, the
medium was changed twice a week. At 80-90% confluence,
cells were harvested with 0.05% trypsin-EDTA (Gibco,
Carlsbad, CA) for 5-10 minutes at 37°C. The cells were
centrifuged at 400 × g for 5 minutes. The resuspended
cells were replated at 1.5 × 106 cells per plate. The culture
medium was changed twice a week.
We also prepared HIG-82 cells (BCRC 60242), rabbit
synovial fibroblasts, which served as a control while
we studied the differentiation potentials of our rabbit
marrow cells. The HIG-82 cells were obtained from the
Bioresource Collection and Research Center (BCRC,
Hsinchu, Taiwan) and were cultured using the same
methods as described above.
Observation of differentiation potentials of rabbit MSCs
The rabbit bone marrow cells obtained from passage 3
were tested for the potential of differentiation into mes-
enchymal tissues.
For osteogenic differentiation, the rabbit cells were
cultured for 3 weeks in DMEM-LG containing 10% FBS,
50 μg/ml ascorbic acid (Sigma-Aldich, St Louis, MO),
10 mM β-glycerophosphate (Calbiochem, San Diego, CA)
and 10-7 M dexamathone (Sigma-Aldich, St Louis, MO).
Then, the cells were rinsed with phosphate-buffered saline
(PBS) (8 mM Na2HPO4, 150 mM NaCl, 2 mM KH2PO4,
3 mM KCl) (pH 7.4) (Sigma-Aldich, St Louis, MO) and
fixed with 4% formaldehyde (Shimakyu Co., Ltd., Osaka,
Japan) in PBS (pH 7.4) at room temperature for 10 minutes.
Finally, the cells were incubated with 2% Alizarin Red
(Sigma-Aldrich, St Louis, MO), pH 4.2, at room temp-
erature for 30 minutes.
For chondrogenic differentiation, the rabbit cells were
plated at 2.5 × 105 cells/35 mm dish (6 well plates), cul-
tured in chondrogenic medium for 3 weeks and stained
with Alcian blue. We also used a 3D culture system [9].
Here is the protocol: 2.5 × 105 rabbit MSCs were placed
in a 15 ml polypropylene tube (Falcon, Bedford, MA),
and centrifuged into pellets. The pellets were cultured at
37°C with 5% CO2 in 1 ml chondrogenic medium; half
of the medium was exchanged for fresh medium every 2to 3 days, for 3 weeks. Under microscopy, the pellets
were embedded in paraffin, cut into 4 μm sections and
stained with Alcian blue (Sigma-Aldrich, St Louis, MO)
solution for 30 minutes at room temperature.
For adipogenic differentiation, the rabbit cells were
cultured for 3 weeks in DMEM-LG containing 10% FBS,
0.5 mM isobutyl-methylxanthine (Sigma-Aldrich, St Louis,
MO), 0.2 mM indomethacin (Sigma-Aldrich, St Louis,
MO), 1 μM dexamethasone (Sigma-Aldrich, St Louis, MO)
and 10 μg/mL insulin (Sigma-Aldrich, St Louis, MO).
Then, the cells were rinsed with PBS (pH 7.4) and fixed
with 4% formaldehyde in PBS (pH 7.4) at room temp-
erature for 10 minutes. Finally, the cells were incubated
with 0.5% Oil Red O (Sigma-Aldrich, St Louis, MO) solu-
tion for 30 minutes at room temperature.
As for the control, the cloned HIG-82 cells (rabbit
fibroblasts) underwent the same staining methods with
Alizarin Red, Alcian blue and Oil Red O, as described
above. The staining results were observed using an
inverted microscope.
FACS analysis and flow cytometry of rabbit MSCs
The rabbit MSCs were characterized for the expression
of surface markers of MSC using FACS analysis with
anti-rabbit CD14 (Antigenix America, Huntington Station,
NY), CD29 (Abcam, Cambridge, MA), CD44 (Antigenix
America, Huntington Station, NY), CD45 (Antigenix
America, Huntington Station, NY) and CD90 (Thermo
Fisher Scientific, Waltham, MA) monoclonal antibodies.
Briefly, the rabbit MSCs at passage 3 were harvested and
suspended in their own culture medium at a concentration
of 1 × 106 cells/ml. The cells underwent primary staining
with mouse anti-rabbit CD14, CD44, CD45, CD29 and
CD90 monoclonal antibodies at room temperature for
30 minutes [2 × 105 cells/0.1 ml in PBS/0.1% bovine serum
albumin (BSA) (Sigma-Aldich, St Louis, MO)]. Then, the
cells were stained with secondary antibody at room
temperature for 30 minutes. The secondary antibody
was rat anti-mouse IgG (H + L)-fluorescein isothiocyanate
(FITC) (eBioscience, San Diego, CA). The cells labeled
with surface antibodies were analyzed 4 times with
flow cytometry on a FACS Caliber cytometer (Becton
Dickinson Biosciences, Heidelberg, Germany). Prior to
flow cytometric analysis, cell samples were washed and
dead cells with debris were excluded. The data were
analyzed with Cell Quest software (Becton Dickinson
Biosciences, Heidelberg, Germany) and the percent-
age of marker-positive cells was shown by Mean ± SD
(n = 4).
Spinal fusion model
We have had extensive experience in performing Boden’s
1995 spinal fusion model [10-12]. Using this model [13],
a bilateral posterolateral intertransverse-process fusion
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white rabbits, each weighing about 3.0 kg and aged
16-20 weeks. The rabbits were anesthetized by intramuscu-
lar injection of Rompun (an anesthetic and muscle relaxant
for animals; Bayer, Leverkusen, Germany) (50 mg/kg), and
Ketalar (ketamine hydrochloride; Parke-Davis, Taipei,
Taiwan) (50 mg/kg). Following infiltration with Xylocaine
(1% lidocaine, Fujisawa, Osaka, Japan), a dorsal 6-cm
midline incision (6 cm above and 1 cm below the poster-
ior iliac crest) was made. This was followed by two para-
median fascial incisions (2 cm lateral to the midline).
Following this, an intermuscular plane was easily devel-
oped in order to expose the transverse processes of L5
and L6 bilaterally. These transverse processes were dec-
orticated using a rongeur. For the 12 animals from the
study group, 1.0 × 108 allogeneic MSCs (at passage 3)
without differentiation loaded on a 4 × 1.5 × 0.3 cm3 sized
scaffold were implanted on each side of the L5-6
intertransverse-process space. For the 12 rabbits from
the control group, only the scaffold was implanted on
each side of the L5-6 intertransverse-process space. The
scaffold we used was a mixture consisting of bioresorba-
ble purified fibrillar collagen and calcium phosphate cer-
amics containing hydroxyapatite (HA) and β-tricalcium
phosphate (β-TCP) (Sunmax Biotechnology CO., Tainan,
Taiwan). The highly purified collagen component was
porcine dermal type I collagen. The ceramic portion was
radiopaque and with a HA/β-TCP ratio of 65/35 - 60/40.
All the animals were cared for in accordance with the
regulations of the National Institutes of Health of the Re-
public of China (Taiwan), and this study protocol was
approved by the Committee for Animal Experimentation
of Chang Gung Memorial Hospital.
Imaging analysis
All rabbits underwent 3-D CT scanning of the lumbar
spine before they were sacrificed at 18 weeks. An excel-
lent fusion was defined as prominent bilateral osseous
growth between the transverse processes without a cleft
and presence of remodeling on the fusion masses. AFigure 1 Definition of fusion results. A. Excellent: prominent osseous gr
B. Good: moderate osseous growth with continuity between bilateral trans
transverse processes with substantial clefts (arrow). D. Poor: scanty osseousgood fusion was defined as a bilateral moderate amount
of osseous growth between the transverse processes
without a cleft on the fusion masses. A fair fusion was
defined as fusion with evidence of osseous growth,
although substantial clefts are present between the trans-
verse processes. A nonfusion was defined as scanty osse-
ous growth with large clefts between the transverses
processes (Figure 1). Excellent and good fusion was cate-
gorized as satisfactory fusion, while fair and poor fusion
was categorized as unsatisfactory fusion. Data were ana-
lyzed using Fisher's exact test, and a P value of less than
0.05 was considered to represent a statistically significant
difference between the study and control groups.
Results
Isolation and culture of rabbit bone marrow MSCs
Under an inverted microscope, minimal fibroblast-like
cells were found adhering to the culture surface at 1 week
after plating (original magnification, 100×). However, a
large amount of cells had adhered to the culture surface,
and showed a fibroblast-like morphology at 2 weeks after
plating (original magnification, 100×) (Figure 2). At 80-
90% confluence, attached cells were harvested for subse-
quent studies.
Differentiation potentials of cloned rabbit marrow cells
The differentiation potentials of rabbit MSCs are shown
in Figure 3. The cells after osteogenic differentiation and
Alizarin red staining showed aggregates or nodules of
calcium under an inverted microscope. Chondrogenic
differentiation and Alcian blue staining showed an ac-
cumulation of sulfated cartilage glycosaminoglycans
(GAGs), which is a component of articular cartilage. After
adipogenic differentiation and Oil Red O staining, they
showed intracellular accumulation of lipid-rich vacuoles.
As for the control, the cloned HIG-82 cells (rabbit fibro-
blasts) that had undergone the same staining methods as
described above showed no accumulation of calcium,
sulfated cartilage glycosaminoglycan or neutral lipid
(Figure 4). The differentiation test showed the clonedowth between bilateral transverse processes with remodeling (arrow).
verse processes (arrow). C. Fair: osseous growth between bilateral
growth between bilateral transverse processes.
Figure 2 Morphology of rabbit marrow cells under inverted microscope (original magnification, 100×). A. Minimal fibroblast-like cells
(arrows) adhering to the culture surface 1 week after seeding. B. A large amount of fibroblast-like cells adhering to the culture surface 2 weeks
after seeding.
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was not present in fibroblasts (mature mesenchymal cells).
Immunophenotypes of rabbit marrow cells
The rabbit MSCs at passage 3 cultured with anti-rabbit
CD14, CD29, CD44, CD45, and CD90 antibodies dis-
played a stable phenotype (Figure 5). These antibody-
labeled cells were analyzed 4 times with flow cytometry
and the percentage of marker-positive cells is shown as
Mean ± SD (n = 4) (Table 1). The current study showed
that 2% of our cells expressed CD14, CD29 and CD45,
and 1% expressed CD90. It also showed that 97%
expressed CD44. Therefore, our rabbit MSCs were nega-
tive for CD14, CD29, CD45, and CD90, but positive for
CD44.
Imaging analysis
In the study group (n = 12), CT scanning revealed excel-
lent fusion in 2 rabbits (17%), good fusion in 8 (66%),
and fair fusion in 2 (17%). In the control-group (n = 12),
a good fusion result was found in 3 rabbits (25%), fair
fusion in 6 (50%), and poor fusion in 3 (25%). Excellent
and good fusion was categorized as satisfactory fusion,
while fair and poor fusion was unsatisfactory fusion.Figure 3 Photomicrography (40×) of rabbit MSCs after differentiation
staining showed calcium deposition (arrow). B. Cells after chondrogenic dif
C. Cells after adipogenic differentiation and staining showed accumulationOn this basis, in the study group, satisfactory fusion
was found in 10 rabbits (83%) and unsatisfactory fusion
in 2 (17%). In the control group, satisfactory fusion was
found in 3 rabbits (25%) and unsatisfactory fusion in 9
(75%). Statistical analysis using Fisher's exact test showed
that the study group had significantly better bone fusion
than the control group, with a P <0 .01.
Discussion
Using Dominici’s definition [1], the immunophenotypic
analysis in the current study showed our rabbit MSCs were
negative for CD14, CD29, CD45, and CD90, while positive
for CD44. However, positive reactivity for CD29 and CD90
was found on human MSCs [1,2,6,7,14,15]. Therefore, the
surface markers of human and rabbit MSCs are not exactly
the same. This finding has also been supported by other re-
ports. Martínez-Lorenzo et al. found that more than 95%
of human MSCs expressed CD90, but only 40% of rabbit
MSCs at passage 1 expressed this marker [7]. Lapi et al. re-
ported that CD90 was absent on rabbit MSCs, but they did
not digitalize the percentage of rabbit MSCs that expressed
CD90 [6]. To our knowledge, this is the first study to find
that less than 2% (fulfilling Dominici’s definition of negative
reactivity) of rabbit MSCs expressed CD90.and relevant staining. A. Cells after osteogenic differentiation and
ferentiation and staining showed glycosaminoglycans (GAGs) (arrow).
of intracellular neutral lipid vacuoles (arrow).
Figure 4 Photomicrography (40×) of HIG-82 cells (rabbit fibroblasts) (control) after a series of staining. A. Alizarin red staining showed no
calcium deposition. B. Alcian blue staining showed no sulfated cartilage glycosaminoglycan. C. Oil Red O staining showed no intracellular
accumulation of neutral lipid vacuoles.
Figure 5 FACS analysis (with 4 flow cytometry procedures) of our rabbit MSCs at passage 3. The study showed that our rabbit MSCs were
negative for CD14, CD29, CD45, and CD90 (column 1, 2, 4, 5), but positive for CD44 (column 3).
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Table 1 The digitalization of the FACS analysis of our
rabbit MSCs at passage 3 showing percentage of
marker-positive cells
1 2 3 4 Mean ± SD
CD14 3.27 1.73 1.9 1.63 2.50 ± 0.77
CD29 0.67 4.28 2.78 3.09 2.71 ± 1.50
CD44 97 99.02 97 97 97.51 ± 1.01
CD45 4.5 0.38 2.78 2.77 2.61 ± 1.69
CD90 1 2.16 0.54 2.21 1.48 ± 0.84
Figure 6 Photomicrography (40×) of the rabbit organs. In one
rabbit that died after implantation of allogeneic differentiated MSCs,
there was myocardial damage with vacuole formation (arrows) (A)
and lung congestion (arrows) (B). In one normal rabbit (control), the
heart and lung showed no myocardial or pulmonary damage (C,D).
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showed that rabbit MSCs promoted spinal fusion. The
MSCs used in the current study were allogeneic undif-
ferentiated cells. According to the literature, both au-
tologous and allogeneic undifferentiated MSCs can heal
bone defects in animals [16,17]. No immunosuppressive
therapy was administered and no adverse immune re-
sponse was detected in the model using allogeneic undif-
ferentiated MSCs [17]. Actually, allogeneic undifferentiated
MSCs could prolong allotransplant survival in a swine
model by reducing the immune response [18]. Although
some reports advocated using autologous MSCs with
osteogenic differentiation to promote spinal fusion [19,20],
we found this modality has shortcomings. First, the
amount of harvested bone marrow cells is limited, so as
not to endanger the animals. Second, it is time-consuming,
as each animal has to wait for several weeks before the
cloned autologous MSCs are available. In contrast, cryo-
preserved allogeneic MSCs isolated from any donor can
provide a readily available source of cells for bone tissue
engineering [17].
We do not recommend using allogeneic differentiated
MSCs to promote spinal fusion. Our preliminary data
show that this modality resulted in an unacceptably high
mortality rate for the animals (6/12, 50%). We hypothe-
sized that this might be due to an adverse immune re-
sponse. The postmortem organs of the rabbits that died
within 3 days after implantation of allogeneic differenti-
ated MSCs showed myocardial damage and pulmonary
congestion (Figure 6).
Collagen has been reported to be useful as a scaffold
for MSCs to repair bone or tendon defects [21,22].
Calcium phosphate ceramics, including hydroxyapatite
(HA) and tricalcium phosphate (TCP), also have been
introduced to carry MSCs to promote animal spinal fu-
sion [23]. As such, many authors preferred using the
combination of collagen and calcium phosphate ceramics
as a scaffold for MSCs to facilitate spinal fusion [8,19].
The current study found scaffolds containing type I
collagen and calcium phosphate ceramics (including
HA and TCP) were effective as carriers for MSCs to pro-
mote fusion.Our results demonstrated the variation of immuno-
phenotypes among human and rabbit bone marrow mes-
enchymal stem cells. In addition, local implantation of
allogenic undifferentiated stem cells could possibly be
applied in promoting spinal fusion in the future.
Conclusions
Immunophenotypic analysis in the current study showed
the surface markers of human and rabbit MSCs are not
exactly the same. The rabbit MSCs showed negative for
CD29 and CD90, while the human MSCs invariably
showed positive for these two markers. The fusion results
of the current study showed that allogeneic undifferenti-
ated rabbit MSCs did not induce an adverse immune re-
sponse and could enhance spinal fusion.
Abbreviations
DMEM-LG: Low-glucose Dulbecco's Modified Eagle Medium;
FACS: Fluorescence activated cell sorter; FBS: Fetal bovine serum;
FITC: Fluorescein isothiocyanate; HA: Hydroxyapatite; MSCs: Mesenchymal
stem cells; PBS: Phosphate-buffered saline; TCP: Tricalcium phosphate.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
THL and YHH led all aspects of this study, including experimental design,
data analysis and interpretation. TCL conceived of the study, carried out all
procedures involving rabbits, and drafted the manuscript. NKC, WCL, PWCC,
and TMS participated in the preparation of the study materials. DJH made
substantial contributions to the provision of study materials. All authors read
and approved the final manuscript.
Acknowledgment
The authors are grateful to note that this work had financial support from
grants provided by the National Science Council of Taiwan (NSC 98-2314-B-
182A-038-MY2 and NSC 100-2314-B-182A-011-MY2). Additional support was
provided by Chang Gung Memorial Hospital, Taiwan (CMRPG890981).
Lee et al. BMC Research Notes 2013, 6:528 Page 7 of 7
http://www.biomedcentral.com/1756-0500/6/528Author details
1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan. 2Department of Neurosurgery, Kaohsiung
Chang Gung Memorial Hospital and Chang Gung University College of
Medicine, Kaohsiung, Taiwan. 3Department of Center for Laboratory Animals,
Kaohsiung Chang Gung Memorial Hospital and Chang Gung University
College of Medicine, Kaohsiung, Taiwan. 4Sunmax Biotechnology CO., LTD.,
Tainan, Taiwan. 5Department of Neurosurgery, Chiayi Chang Gung Memorial
Hospital, Chiayi, Taiwan.
Received: 29 May 2013 Accepted: 3 December 2013
Published: 10 December 2013References
1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D,
Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining
multipotent mesenchymal stromal cells. The international society for
cellular therapy position statement. Cytotherapy 2006, 8:315–317.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD,
Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential
of adult human mesenchymal stem cells. Science 1999, 284:143–147.
3. Deans RJ, Moseley AB: Mesenchymal stem cells: biology and potential
clinical uses. Exp Hematol 2000, 28:875–884.
4. Bianco P, Gehron Robey P: Marrow stromal stem cells. J Clin Invest 2000,
105:1663–1668.
5. Karaoz E, Aksoy A, Ayhan S, Sariboyaci AE, Kaymaz F, Kasap M: Characterization
of mesenchymal stem cells from rat bone marrow: ultrastructural properties,
differentiation potential and immunophenotypic markers. Histochem Cell Biol
2009, 132:533–546.
6. Lapi S, Nocchi F, Lamanna R, Passeri S, Iorio M, Paolicchi A, Urciuoli P, Coli A,
Abramo F, Miragliotta V, Giannessi E, Stornelli MR, Vanacore R, Stampacchia G,
Pisani G, Borghetti L, Scatena F: Different media and supplements modulate
the clonogenic and expansion properties of rabbit bone marrow
mesenchymal stem cells. BMC Res Notes 2008, 1:53.
7. Martínez-Lorenzo MJ, Royo-Cañas M, Alegre-Aguarón E, Desportes P,
Castiella T, García-Alvarez F, Larrad L: Phenotype and chondrogenic
differentiation of mesenchymal cells from adipose tissue of different species.
J Orthop Res 2009, 27:1499–1507.
8. Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K: Evaluation of
posterolateral spinal fusion using mesenchymal stem cells: differences
with or without osteogenic differentiation. Spine (Phila Pa 1976) 2007,
32:2432–2436.
9. Bosnakovski D, Mizuno M, Kim G, Ishiguro T, Okumura M, Iwanaga T,
Kadosawa T, Fujinaga T: Chondrogenic differentiation of bovine bone
marrow mesenchymal stem cells in pellet cultural system. Exp Hematol
2004, 32:502–509.
10. Lee TC, Ho JT, Hung KS, Chen WF, Chung YH, Yang YL: Bone morphogenetic
protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion
experiment. Neurosurgery 2006, 58:373–380.
11. Lee TC, Wang CJ, Yang YL, Huang YH, Lin WC, Chang SY: Bone
morphogenetic protein-2 expression in spinal fusion masses enhanced
by extracorporeal shock wave treatment: a rabbit experiment. Acta
Neurochir (Wien) 2010, 152:1779–1784.
12. Lee TC, Yang YL, Chang NK, Lin TS, Lin WC, Liu YS, Wang CJ: Biomechanical
testing of spinal fusion segments enhanced by extracorporeal shock
wave treatment in rabbits. Chang Gung Med J 2009, 32:276–282.
13. Boden SD, Schimandle JH, Hutton WC: An experimental lumbar
intertransverse process spinal fusion model. Radiographic, histologic,
and biomechanical healing characteristics. Spine (Phila Pa 1976) 1995,
20:412–420.
14. Blanco JF, Graciani IF, Sanchez-Guijo FM, Muntión S, Hernandez-Campo P,
Santamaria C, Carrancio S, Barbado MV, Cruz G, Gutierrez-Cosío S, Herrero C,
San Miguel JF, Briñon JG, del Cañizo MC: Isolation and characterization of
mesenchymal stromal cells from human degenerated nucleus pulposus:
comparison with bone marrow mesenchymal stromal cells from the
same subjects. Spine (Phila Pa 1976) 2010, 35:2259–2265.
15. Stich S, Loch A, Leinhase I, Neumann K, Kaps C, Sittinger M, Ringe J: Human
periosteum-derived progenitor cells express distinct chemokine receptors
and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and
CXCL13. Eur J Cell Biol 2008, 87:365–376.16. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S: The effect of implants
loaded with autologous mesenchymal stem cells on the healing of
canine segmental bone defects. J Bone Joint Surg Am 1998, 80:985–996.
17. Arinzeh TL, Peter SJ, Archambault MP, van den Bos C, Gordon S, Kraus K,
Smith A, Kadiyala S: Allogeneic mesenchymal stem cells regenerate bone
in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003,
85-A:1927–1935.
18. Kuo YR, Goto S, Shih HS, Wang FS, Lin CC, Wang CT, Huang EY, Chen CL,
Wei FC, Zheng XX, Lee WP: Mesenchymal stem cells prolong composite
tissue allotransplant survival in a swine model. Transplantation 2009,
87:1769–1777.
19. Minamide A, Yoshida M, Kawakami M, Yamasaki S, Kojima H, Hashizume H,
Boden SD: The use of cultured bone marrow cells in type I collagen gel
and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine
(Phila Pa 1976) 2005, 30:1134–1138.
20. Cinotti G, Patti AM, Vulcano A, Della Rocca C, Polveroni G, Giannicola G,
Postacchini F: Experimental posterolateral spinal fusion with porous
ceramics and mesenchymal stem cells. J Bone Joint Surg Br 2004,
86:135–142.
21. Undale A, Fraser D, Hefferan T, Kopher RA, Herrick J, Evans GL, Li X, Kakar S,
Hayes M, Atkinson E, Yaszemski MJ, Kaufman DS, Westendorf JJ, Khosla S:
Induction of fracture repair by mesenchymal cells derived from human
embryonic stem cells or bone marrow. J Orthop Res 2011, 29:1804–1811.
22. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ: Use of
mesenchymal stem cells in a collagen matrix for Achilles tendon repair.
J Orthop Res 1998, 16:406–413.
23. Goldschlager T, Rosenfeld JV, Ghosh P, Itescu S, Blecher C, McLean C, Jenkin G:
Cervical interbody fusion is enhanced by allogeneic mesenchymal precursor
cells in an ovine model. Spine (Phila Pa 1976) 2011, 36:615–623.
doi:10.1186/1756-0500-6-528
Cite this article as: Lee et al.: Characterization and spinal fusion effect of
rabbit mesenchymal stem cells. BMC Research Notes 2013 6:528.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
